Research programme: anticancer therapeutics - Meridian LabAlternative Names: Captisol-enabled® docetaxel; Captisol-enabled® taxotere; ML-061; ML-141
Latest Information Update: 16 Jul 2016
At a glance
- Originator Meridian Lab
- Class Small molecules; Taxanes
- Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer